🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Canada says tensions did not 'necessarily' end COVID-19 vaccine partnership with China

Published 2020-08-27, 01:37 p/m
© Reuters. China's vaccine specialist CanSino Biologics Inc in Tianjin

By Steve Scherer

OTTAWA (Reuters) - The end to a partnership on a coronavirus vaccine between Chinese firm CanSino Biologics and Canada's National Research Council was not "necessarily" tied to diplomatic tensions between the two countries, Canada's foreign minister said on Thursday.

Canadian Foreign Minister Francois-Philippe Champagne met his Chinese counterpart Wang Yi for about 90 minutes on Tuesday in Rome, where he urged Beijing to release two Canadian citizens it has detained.

The two ministers also "discussed the importance of global collaboration in the face of COVID-19, including the search for a vaccine," according to a statement.

The following day Canada's National Research Council said it had ended its partnership on a coronavirus vaccine with CanSino because the company lacked the authority to ship the vaccine at this time.

"We are going through a difficult time" in bilateral relations, Champagne told reporters on a teleconference call from Beirut, "but I would not necessarily make a link between that discussion and the Canadian or the Chinese position."

Ties between the two countries deteriorated in December 2018 after Canadian police detained Meng Wanzhou, chief financial officer of Huawei Technologies Co Ltd [HWT.UL], on a U.S. extradition warrant.

Soon after, China arrested Canadians Michael Spavor and Michael Kovrig and charged them with spying. It also blocked imports of some canola seed.

The end of the vaccine collaboration had nothing to do with soured diplomatic relations, Chinese foreign ministry spokesman Zhao Lijian said at a daily news briefing earlier on Thursday.

Champagne also did not rule out collaboration with China or Chinese companies on health issues or COVID-19 in the future.

"When it comes to global health, when it comes to issues around global health and managing issues around COVID, I think it is wise for us to be talking to each other," Champagne added.

© Reuters. China's vaccine specialist CanSino Biologics Inc in Tianjin

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.